Search

Ian Ganly Phones & Addresses

  • 425 Main St PH 1B, New York, NY 10044 (646) 861-2826
  • 425 Main St, New York, NY 10044
  • 17 Stony Hill Rd, Ridgefield, CT 06877

Work

Company: MSKCC SURGERY GROUP Address: 1275 York Ave, New York, NY 10065 Phones: (800) 525-2225

Education

School / High School: University Of Glasgow, Faculty Of Medicine 1989

Languages

English

Images

Industries

Hospital & Health Care

Specialities

General Surgery • Ear, Nose, and Throat

Professional Records

Medicine Doctors

Ian Ganly Photo 1

Dr. Ian Ganly, New York NY - MD (Doctor of Medicine)

View page
Specialties:
General Surgery
Ear, Nose, and Throat
Address:
MSKCC SURGERY GROUP
1275 York Ave, New York, NY 10065
(800) 525-2225 (Phone)

MSKCC
1275 York Ave, New York, NY 10065
(866) 425-8999 (Phone)
Languages:
English
Hospitals:
MSKCC SURGERY GROUP
1275 York Ave, New York, NY 10065

MSKCC
1275 York Ave, New York, NY 10065

Memorial Sloan - Kettering Cancer Center
1275 York Avenue, New York, NY 10065
Philosophy:
Dr. Ganly has special expertise in the surgical treatment of benign and malignant tumors in the head and neck area including tumors of the mouth, throat, larynx (voicebox), esophagus (swallowing tube), sinuses, thyroid gland, salivary glands, head and neck skin cancer and melanoma. His surgical expertise has been developed with his training in otolaryngology, general surgery, and plastic surgery, giving him the full repertoire of skills necessary to tackle head and neck tumors. In addition to traditional open surgery, Dr Ganly has a special interest in endoscopic laser resection of tumors of the larynx and pharynx. He trained with Professor Wolfgang Steiner, the pioneer of endoscopic laser surgery. This form of surgery involves no external cuts, as all surgery is performed through an endoscope inserted in the patient’s mouth. The procedure is therefore minimally invasive and can often be carried out on an outpatient basis. The procedure helps to preserve the patient’s speech and swallowing functions, allowing patients to rehabilitate far more quickly than after traditional open surgery. Dr. Ganly is also interested in head and neck cancer research, and his dedicated three years of full-time head and neck cancer laboratory research resulted in his earning a PhD degree in 1999. He has two principal areas of research: a) Molecular therapeutics, which involves developing new therapies/agents which selectively kill cancer cells but not normal cells; b) Gene expression profiling, which involves identification of genes which predict a poor outcome, so that patients who have these genes can be targeted for more-aggressive treatments to cure their cancer. His interest in both surgery and research was recognized by Memorial Sloan-Kettering Cancer Center with the conferring of the prestigious Michael E. Burt Fellow of the Year award in 2004 for outstanding surgical excellence. Dr. Ganly’s award, granted by the surgical staff at Memorial Hospital, resulted from competitive consideration of more than 60 outstanding fellows in surgery. Dr. Ganly has published more than 30 scientific articles and written several book chapters in the field of head and neck cancer. He has presented at more than 40 national and international meetings and is an active reviewer for several journals, including Head and Neck, Clinical Otolaryngology, Archives of Otolaryngology-Head and Neck Surgery, and Surgical Oncology.
Education:
Medical School
University Of Glasgow, Faculty Of Medicine
Graduated: 1989
Ian Ganly Photo 2

Ian Ganly

View page
Specialties:
Otolaryngology
Work:
Memorial Sloan Kettering Cancer Center
1275 York Ave, New York, NY 10065
(212) 639-2000 (phone), (646) 422-0298 (fax)
Languages:
English
Description:
Dr. Ganly works in New York, NY and specializes in Otolaryngology. Dr. Ganly is affiliated with Bellevue Hospital Center, Memorial Sloan Kettering Cancer Center, New York Presbyterian Hospital Columbia University Medical Center and New York Presbyterian Westchester Division.
Ian Ganly Photo 3

Ian Ganly

View page
Specialties:
Otolaryngology
Plastic Surgery within the Head & Neck
Plastic Surgery Within the Head and Neck
Education:
University Of Glasgow (1989)
Ian Ganly Photo 4

Ian Ganly, New York NY

View page
Specialties:
Ear, Nose & Throat Doctor
Address:
1275 York Ave, New York, NY 10065

Resumes

Resumes

Ian Ganly Photo 5

Head And Neck Surgeon

View page
Location:
New York, NY
Industry:
Hospital & Health Care
Work:
Memorial Sloan Kettering Cancer Center
Head and Neck Surgeon

Business Records

Name / Title
Company / Classification
Phones & Addresses
Ian Ganly
Ian Ganly MD,PHD
Ent
1275 York Ave, New York, NY 10065
(800) 525-2225

Publications

Us Patents

Mutant Viruses

View page
US Patent:
20070003520, Jan 4, 2007
Filed:
Nov 17, 2004
Appl. No.:
10/579622
Inventors:
Susanne Brown - Glasgov, GB
Bhuvanesh Singh - New York NY, US
Ian Ganly - New York NY, US
Paul Dunn - Glasgow, GB
International Classification:
A61K 48/00
C12N 7/00
US Classification:
424093200, 424093600, 435235100
Abstract:
An herpes simplex virus wherein the herpes simplex virus genome comprises nucleic acid encoding an antisense to the squamous cell carcinoma related oncogene (asSCCRO); and an herpes simplex virus wherein the herpes simplex virus genome comprises nucleic acid encoding a short interfering ribonucleic acid (siRNA) molecule that is capable of repressing or silencing expression of squamous cell carcinoma related oncogene (SCCRO) nucleic acid or polypeptide are disclosed together with methods for generation and applications of such viruses.

Mutant Viruses

View page
US Patent:
20090274728, Nov 5, 2009
Filed:
May 6, 2009
Appl. No.:
12/436382
Inventors:
Susanne Moira Brown - Glasgow, GB
Bhuvanesh Singh - Old Westbury NY, US
Ian Ganly - New York NY, US
Paul Dunn - Glasgow, GB
Assignee:
CRUSADE LABORATORIES LIMITED - Glasgow
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH - New York NY
International Classification:
A61K 39/245
C12N 7/01
A61K 35/76
C12N 15/66
US Classification:
4242311, 4352351, 424 936, 435 9141
Abstract:
An herpes simplex virus wherein the herpes simplex virus genome comprises nucleic acid encoding an antisense to the squamous cell carcinoma related oncogene (asSCCRO); and an herpes simplex virus wherein the herpes simplex virus genome comprises nucleic acid encoding a short interfering ribonucleic acid (siRNA) molecule that is capable of repressing or silencing expression of squamous cell carcinoma related oncogene (SCCRO) nucleic acid or polypeptide are disclosed together with methods for generation and applications of such viruses.
Ian Ganly from New York, NY, age ~61 Get Report